A phase III randomized trial of intensive induction and consolidation chemotherapy +/- oblimersen, a pro-apoptotic Bcl-2 antisense oligonucleotide in untreated acute myeloid leukemia patients >60 years old
- Citation:
- J Clin Oncol vol 25 (18s) abstr 7012
- Meeting Instance:
- ASCO 2007
- Year:
- 2007
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 3436
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- G. Marcucci B. K. Moser W. G. Blum W. Stock M. Wetzler J. E. Kolitz M. C. Thakuri T. H. Carter R. K. Stuart R. A. Larson
- Networks:
- Study
- CALGB-10201
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords: